| 摘要 |
The invention is directed to improved methods for modulating the human sexual response by administering a vasodilator, selected from the group consisting of phentolamine, phentolamine mesylate, phentolamine hydrochloride, apomorphine, phenoxybenzamine, nitroglycerin, thymoxamine, nicotinyl alcohol, imipramine, verapamil, isoxsuprine, naftidrofuryl, tolazoline and papaverine, to the circulation through transmucosal, including but not limited to, administration through the vaginal mucosa, transdermal, intranasal or rectal routes of administration.
|
| 申请人 |
ZONAGEN, INC.;PODOLSKI, JOSEPH, S. |
发明人 |
ZORGNIOTTI, ANDRIAN DI;PODOLSKI, JOSEPH, S. |
